Skip to main content
Top
Published in: Familial Cancer 3/2014

01-09-2014 | Original Article

Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors

Authors: Andreas Dinkel, Marielouise Kornmayer, Jürgen E. Gschwend, Birgitt Marten-Mittag, Peter Herschbach, Kathleen Herkommer

Published in: Familial Cancer | Issue 3/2014

Login to get access

Abstract

Familial clustering is common in prostate cancer (PCa), but the psychosocial consequences of being a PCa patient in an affected family are not well understood. This study investigated the effects of family history of PCa on psychosocial distress and perceived psychosocial treatment need. Data were gathered within the German national research project “Familial Prostate Cancer”. 4.123 PCa survivors who had undergone prostatectomy at least 4 years ago received a questionnaire set. 3.623 of the respondents [68.3 % sporadic, sporadic prostate cancer (SPCa); 31.7 % familial, familial prosate cancer (FPCa)] filled in measures of cancer-specific distress (QSC-R10), depression (PHQ-2), and anxiety (GAD-2). Perceived psychosocial treatment need was assessed using a single item. The prevalence of psychosocial distress did not differ between SPCa and FPCa survivors (cancer-specific distress: 16.2 vs. 16.7 %; depression: 5.8 vs. 6.4 %; anxiety: 6.6 vs. 5.8 %; ps ≥ .397). Similarly, psychosocial treatment need did not differ between SPCa (11.8 %) and FPCa (13.1 %) cases (p = .303). However, family history moderated the effect of cancer-specific distress on treatment need (OR 2.67, 95 % CI 1.43–4.96, p = .002). Exploratory analyses for the hereditary subtype (HPCa) revealed that cancer-specific distress was lower in HPCa survivors who had only daughters compared to survivors without any children or with at least one son. No such effect was observed in SPCa survivors (p = .040). PCa survivors with a positive family history do not experience increased psychosocial distress. Nonetheless, family history may exert subtle effects that deserve further research.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403PubMedCrossRef Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403PubMedCrossRef
3.
go back to reference Robert Koch-Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (ed): Krebs in Deutschland 2007/2008 [Cancer in Germany 2007/2008]. Berlin, 2012 Robert Koch-Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (ed): Krebs in Deutschland 2007/2008 [Cancer in Germany 2007/2008]. Berlin, 2012
4.
go back to reference Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789–794PubMedCrossRef Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789–794PubMedCrossRef
5.
go back to reference Bruner DW, Moore D, Parlanti D et al (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107:797–803PubMedCrossRef Bruner DW, Moore D, Parlanti D et al (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107:797–803PubMedCrossRef
6.
go back to reference Brandt A, Bermejo JL, Sundquist J et al (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58:275–280PubMedCrossRef Brandt A, Bermejo JL, Sundquist J et al (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58:275–280PubMedCrossRef
7.
go back to reference Hemminki K (2012) Familial risk and familial survival in prostate cancer. World J Urol 30:143–148PubMedCrossRef Hemminki K (2012) Familial risk and familial survival in prostate cancer. World J Urol 30:143–148PubMedCrossRef
8.
9.
go back to reference Herkommer K, Schmidt C, Gschwend JE (2011) Zehn Jahre nationales Forschungsprojekt “Familiäres Prostatakarzinom”. Probleme der Identifikation von Risikofamilien [Ten years national research project “Familial Prostate Cancer”. Problems in identifying risk families]. Urologe 50:813–820PubMedCrossRef Herkommer K, Schmidt C, Gschwend JE (2011) Zehn Jahre nationales Forschungsprojekt “Familiäres Prostatakarzinom”. Probleme der Identifikation von Risikofamilien [Ten years national research project “Familial Prostate Cancer”. Problems in identifying risk families]. Urologe 50:813–820PubMedCrossRef
10.
go back to reference Siddiqui SA, Sengupta S, Slezak JM et al (2006) Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. J Urol 176:1118–1121PubMedCrossRef Siddiqui SA, Sengupta S, Slezak JM et al (2006) Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. J Urol 176:1118–1121PubMedCrossRef
11.
go back to reference Colloca G, Venturino A (2011) The evolving role of familial history for prostate cancer. Acta Oncol 50:14–24PubMedCrossRef Colloca G, Venturino A (2011) The evolving role of familial history for prostate cancer. Acta Oncol 50:14–24PubMedCrossRef
12.
go back to reference Eeles RA, Olama AA, Benlloch S et al (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 45:385–391PubMedCrossRef Eeles RA, Olama AA, Benlloch S et al (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 45:385–391PubMedCrossRef
14.
go back to reference Rubin MA, Maher CA, Chinnaiyan AM (2011) Common gene rearrangements in prostate cancer. J Clin Oncol 29:3659–3668PubMedCrossRef Rubin MA, Maher CA, Chinnaiyan AM (2011) Common gene rearrangements in prostate cancer. J Clin Oncol 29:3659–3668PubMedCrossRef
15.
go back to reference Carter B, Bova G, Beaty Y et al (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150:797–802PubMed Carter B, Bova G, Beaty Y et al (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150:797–802PubMed
16.
go back to reference Kupelian PA, Reddy CA, Reuther AM et al (2006) Aggressiveness of familial prostate cancer. J Clin Oncol 24:3445–3450PubMedCrossRef Kupelian PA, Reddy CA, Reuther AM et al (2006) Aggressiveness of familial prostate cancer. J Clin Oncol 24:3445–3450PubMedCrossRef
17.
go back to reference Lee KL, Marotte JB, Ferrari MK et al (2005) Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy. Urology 65:311–315PubMedCrossRef Lee KL, Marotte JB, Ferrari MK et al (2005) Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy. Urology 65:311–315PubMedCrossRef
18.
go back to reference Roehl KA, Loeb S, Antenor JAV et al (2006) Characteristics of patients with familial versus sporadic prostate cancer. J Urol 176:2438–2442PubMedCrossRef Roehl KA, Loeb S, Antenor JAV et al (2006) Characteristics of patients with familial versus sporadic prostate cancer. J Urol 176:2438–2442PubMedCrossRef
19.
go back to reference Rouprêt M, Fromont G, Bitker MO et al (2006) Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology 67:1028–1032PubMedCrossRef Rouprêt M, Fromont G, Bitker MO et al (2006) Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology 67:1028–1032PubMedCrossRef
20.
go back to reference Heck MM, Kron M, Gschwend JE et al (2012) Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer. Eur J Cancer 48:1312–1317PubMedCrossRef Heck MM, Kron M, Gschwend JE et al (2012) Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer. Eur J Cancer 48:1312–1317PubMedCrossRef
21.
go back to reference Jacobson PB, Lamonde LA, Honour M et al (2004) Relation of family history of prostate cancer to perceived vulnerability and screening behaviour. Psychooncology 13:80–85CrossRef Jacobson PB, Lamonde LA, Honour M et al (2004) Relation of family history of prostate cancer to perceived vulnerability and screening behaviour. Psychooncology 13:80–85CrossRef
22.
go back to reference McDowell ME, Occhipinti S, Gardiner RA et al (2013) Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer. Psychooncology 22:2496–2504PubMedCrossRef McDowell ME, Occhipinti S, Gardiner RA et al (2013) Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer. Psychooncology 22:2496–2504PubMedCrossRef
23.
go back to reference Meiser B, Cowan R, Costello A et al (2007) Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men’s screening uptake. Urology 70:738–742PubMedCrossRef Meiser B, Cowan R, Costello A et al (2007) Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men’s screening uptake. Urology 70:738–742PubMedCrossRef
24.
go back to reference Cormier L, Valéri A, Azzouzi R et al (2002) Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 51:276–285PubMedCrossRef Cormier L, Valéri A, Azzouzi R et al (2002) Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 51:276–285PubMedCrossRef
25.
go back to reference Bratt O, Damber JE, Emanuelsson M et al (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 36:235–241PubMedCrossRef Bratt O, Damber JE, Emanuelsson M et al (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 36:235–241PubMedCrossRef
26.
go back to reference Matthew AG, Paradiso C, Currie KL et al (2011) Examining risk perception among men with a family history of prostate cancer. Patient Educ Couns 85:251–257PubMedCrossRef Matthew AG, Paradiso C, Currie KL et al (2011) Examining risk perception among men with a family history of prostate cancer. Patient Educ Couns 85:251–257PubMedCrossRef
27.
go back to reference Tavlarides AM, Ames SC, Diehl NN et al (2013) Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. Psychooncology 22:1328–1335PubMedCrossRef Tavlarides AM, Ames SC, Diehl NN et al (2013) Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. Psychooncology 22:1328–1335PubMedCrossRef
28.
go back to reference Paiss T, Herkommer K, Bock B et al (2003) Association between the clinical presentation and epiemiological features of familial prostate cancer in patients selected for radical prostatectomy. Eur Urol 43:615–621PubMedCrossRef Paiss T, Herkommer K, Bock B et al (2003) Association between the clinical presentation and epiemiological features of familial prostate cancer in patients selected for radical prostatectomy. Eur Urol 43:615–621PubMedCrossRef
29.
go back to reference Book K, Marten-Mittag B, Henrich G et al (2011) Distress screening in oncology—evaluation of the Questionnaire on Distress in Cancer Patients-Short Form (QSC-R10) in a German sample. Psychooncology 20:287–293PubMedCrossRef Book K, Marten-Mittag B, Henrich G et al (2011) Distress screening in oncology—evaluation of the Questionnaire on Distress in Cancer Patients-Short Form (QSC-R10) in a German sample. Psychooncology 20:287–293PubMedCrossRef
30.
go back to reference Herschbach P, Marten-Mittag B, Henrich G (2003) Revision und psychometrische Prüfung des Fragebogens zur Belastung von Krebskranken (FBK-R23) [Revision and psychometric properties of the Questionnaire on Stress in Cancer Patients (QSC-R23)]. Z Med Psychol 12:69–76 Herschbach P, Marten-Mittag B, Henrich G (2003) Revision und psychometrische Prüfung des Fragebogens zur Belastung von Krebskranken (FBK-R23) [Revision and psychometric properties of the Questionnaire on Stress in Cancer Patients (QSC-R23)]. Z Med Psychol 12:69–76
31.
go back to reference Herschbach P, Keller M, Knight L et al (2004) Psychological problems of cancer patients: a cancer specific distress screening with a cancer-specific questionnaire. Br J Cancer 91:504–511PubMedPubMedCentralCrossRef Herschbach P, Keller M, Knight L et al (2004) Psychological problems of cancer patients: a cancer specific distress screening with a cancer-specific questionnaire. Br J Cancer 91:504–511PubMedPubMedCentralCrossRef
32.
go back to reference Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of the PRIME-MD: the PHQ primary care study. JAMA 282:1737–1744PubMedCrossRef Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of the PRIME-MD: the PHQ primary care study. JAMA 282:1737–1744PubMedCrossRef
33.
go back to reference Gräfe K, Zipfel S, Herzog W et al (2004) Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Ergebnisse der deutschen Validierungsstudie [Screening for psychiatric disorders with the Patient Health Questionnaire: results from the German validation study]. Diagnostica 50:171–181CrossRef Gräfe K, Zipfel S, Herzog W et al (2004) Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Ergebnisse der deutschen Validierungsstudie [Screening for psychiatric disorders with the Patient Health Questionnaire: results from the German validation study]. Diagnostica 50:171–181CrossRef
34.
go back to reference Löwe B, Wahl I, Rose M et al (2010) A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 122:86–95PubMedCrossRef Löwe B, Wahl I, Rose M et al (2010) A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 122:86–95PubMedCrossRef
35.
go back to reference Dinkel A, Berth H, Tchitchekian G et al (2010) Bedürfnis nach psychosozialer Beratung und Inanspruchnahme psychosozialer Hilfen bei Krebspatienten [Perceived need for psychosocial support and utilization of support services in cancer patients]. In: Berth H (ed) Psychologie und Medizin. Lengerich, Pabst, pp 107–117 Dinkel A, Berth H, Tchitchekian G et al (2010) Bedürfnis nach psychosozialer Beratung und Inanspruchnahme psychosozialer Hilfen bei Krebspatienten [Perceived need for psychosocial support and utilization of support services in cancer patients]. In: Berth H (ed) Psychologie und Medizin. Lengerich, Pabst, pp 107–117
36.
go back to reference Geirdal AØ, Dahl AA (2008) The relationship between psychological distress and personality in women from families with familial breast/ovarian or hereditary non-polyposis colorectal cancer in the absence of demonstrated mutations. J Genet Counsel 17:384–393CrossRef Geirdal AØ, Dahl AA (2008) The relationship between psychological distress and personality in women from families with familial breast/ovarian or hereditary non-polyposis colorectal cancer in the absence of demonstrated mutations. J Genet Counsel 17:384–393CrossRef
37.
go back to reference Hamilton JG, Lobel M, Moyer A (2009) Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 28:510–518PubMedPubMedCentralCrossRef Hamilton JG, Lobel M, Moyer A (2009) Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 28:510–518PubMedPubMedCentralCrossRef
38.
go back to reference Gopie JP, Vasen HFA, Tibben A (2012) Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?—a systematic review. Crit Rev Oncol Hematol 83:329–340PubMedCrossRef Gopie JP, Vasen HFA, Tibben A (2012) Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?—a systematic review. Crit Rev Oncol Hematol 83:329–340PubMedCrossRef
39.
go back to reference Rabkin C, Rogers ML, Pinto BM et al (2007) Effect of personal cancer history and family cancer history on levels of psychological distress. Soc Sci Med 64:411–416CrossRef Rabkin C, Rogers ML, Pinto BM et al (2007) Effect of personal cancer history and family cancer history on levels of psychological distress. Soc Sci Med 64:411–416CrossRef
40.
go back to reference Kowalkowski MA, Hart SL, Du XL et al (2012) Cancer perceptions: implications from the 2007 Health Information National Trends Survey. J Cancer Surviv 6:287–295PubMedCrossRef Kowalkowski MA, Hart SL, Du XL et al (2012) Cancer perceptions: implications from the 2007 Health Information National Trends Survey. J Cancer Surviv 6:287–295PubMedCrossRef
41.
go back to reference Mols F, van de Poll-Franse LV, Vingerhoets JJM et al (2006) Long-term quality of life among Dutch prostate cancer survivors. Results of a population-based study. Cancer 107:2186–2196PubMedCrossRef Mols F, van de Poll-Franse LV, Vingerhoets JJM et al (2006) Long-term quality of life among Dutch prostate cancer survivors. Results of a population-based study. Cancer 107:2186–2196PubMedCrossRef
42.
go back to reference Boorjian SA, Eastham JA, Graefen M et al (2012) A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol 61:664–675PubMedCrossRef Boorjian SA, Eastham JA, Graefen M et al (2012) A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol 61:664–675PubMedCrossRef
43.
go back to reference Kibel AS, Ciezki JP, Klein EA et al (2012) Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol 187:1259–1265PubMedCrossRef Kibel AS, Ciezki JP, Klein EA et al (2012) Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol 187:1259–1265PubMedCrossRef
44.
go back to reference Hruza B, Bermejo JL, Flinspach B et al (2013) Long-term oncological outcomes after laparoscopic radical prostatectomy. BJU Int 111:271–280PubMedCrossRef Hruza B, Bermejo JL, Flinspach B et al (2013) Long-term oncological outcomes after laparoscopic radical prostatectomy. BJU Int 111:271–280PubMedCrossRef
45.
go back to reference Walter FM, Emery J (2005) ‘Coming down the line’—patients’ understanding of their family history of common chronic disease. Ann Fam Med 3:405–414PubMedPubMedCentralCrossRef Walter FM, Emery J (2005) ‘Coming down the line’—patients’ understanding of their family history of common chronic disease. Ann Fam Med 3:405–414PubMedPubMedCentralCrossRef
46.
go back to reference Spencer BA, Babey SH, Etzioni DA et al (2006) A population-based survey of prostate-specific antigen testing among California men at high risk for prostate carcinoma. Cancer 176:765–774CrossRef Spencer BA, Babey SH, Etzioni DA et al (2006) A population-based survey of prostate-specific antigen testing among California men at high risk for prostate carcinoma. Cancer 176:765–774CrossRef
47.
go back to reference Wallner LP, Sarma AV, Lieber MM et al (2008) Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County Study. Cancer Epidemiol Biomarkers Prev 17:3588–3592PubMedPubMedCentralCrossRef Wallner LP, Sarma AV, Lieber MM et al (2008) Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County Study. Cancer Epidemiol Biomarkers Prev 17:3588–3592PubMedPubMedCentralCrossRef
48.
go back to reference Patenaude AF, DeMarco TA, Peshkin BN et al (2013) Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Counsel 22:303–314CrossRef Patenaude AF, DeMarco TA, Peshkin BN et al (2013) Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Counsel 22:303–314CrossRef
49.
go back to reference Esplen MJ, Madlensky L, Aronson M et al (2007) Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet 72:394–401PubMedCrossRef Esplen MJ, Madlensky L, Aronson M et al (2007) Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet 72:394–401PubMedCrossRef
50.
51.
go back to reference Stinesen-Kollberg K, Thorsteinsdottir T, Wilderäng U et al (2013) Worry about one’s own children, psychological well-being, and interest in psychosocial intervention. Psychooncology 22:2117–2123PubMedCrossRef Stinesen-Kollberg K, Thorsteinsdottir T, Wilderäng U et al (2013) Worry about one’s own children, psychological well-being, and interest in psychosocial intervention. Psychooncology 22:2117–2123PubMedCrossRef
52.
go back to reference Eisinger F, Bouhnik AD, Malavolti L et al (2011) Cancer survivors: familial risk perception and management advice given to their relatives. Fam Cancer 10:147–155PubMedCrossRef Eisinger F, Bouhnik AD, Malavolti L et al (2011) Cancer survivors: familial risk perception and management advice given to their relatives. Fam Cancer 10:147–155PubMedCrossRef
Metadata
Title
Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors
Authors
Andreas Dinkel
Marielouise Kornmayer
Jürgen E. Gschwend
Birgitt Marten-Mittag
Peter Herschbach
Kathleen Herkommer
Publication date
01-09-2014
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2014
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-014-9715-6

Other articles of this Issue 3/2014

Familial Cancer 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine